Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® anti-biotin reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® cd133 reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® cd14 reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® cd19 reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® cd3 reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs cd34 reagent is intended for the in vitro enrichment of human cd34 positive hematopoietic progenitor cells from heterogeneous hematologic cell populations in combination with the clinimacs system only.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® cd4 reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® cd56 reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® cd8 reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.

Singapore - English - HSA (Health Sciences Authority)

miltenyi biotec asia pacific pte. ltd. - general hospital - the clinimacs® cytokine capture system (ifn-gamma) is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the clinimacs® system.